Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Sr. Manager, Pharma and Biotech Segment
Connect with Nicki Catchpole on LinkedIn
Follow Nicki Catchpole on Twitter
About the author:
As a professional with over 14 years of experience in strategy development and partnership management across a variety of industries, Nicki’s latest role as a Senior Manager, Segment Marketing at Elsevier applies her skills to the area of drug discovery and development in the Pharma and Biotech industry.
In this capacity she is focused on understanding biopharmaceutical R&D challenges and turning them into opportunity to further Elsevier’s ability to serve industry executives and the professionals who innovate in the drug discovery and development space. Prior to joining Elsevier, Nicki held senior alliance and strategy roles in the Legal, Tax & Accounting, Life Sciences and Cyber Security industries.
Nicki resides in New York City and holds a BA in English Literature and Mandarin Chinese from Carleton College in Northfield, MN.
Posts by Nicki Catchpole
Posted on April 15th, 2019 in The Hive
4P Pharmaceutical is an Elsevier partner and Hive participant who has leveraged solutions to further their early stage drug development process. They’ve made great strides in particular with the Elsevier.(more…)
Posted on April 13th, 2019 in Pharma R&D
Beacon Discovery is a selected member of Elsevier’s The Hive, which is a partnership engine supporting innovation and R&D with emerging biotech startups. Here, Dr. Carleton Sage explains how leveraging the Elsevier suite of solutions in conjunction with an impassioned approach to GCPR research, Beacon Discovery has made significant strides in the discovery process to solve unmet medical needs.(more…)
Posted on March 15th, 2019 in Pharma R&D
For many, many years, the findings of scientific research were published in an always-growing collection of scientific journals that spun off into more and more specialized disciplines. Today’s scientists have to think far beyond scholarly journals subscriptions and wrestle instead with search strategies and informatics.
Posted on March 12th, 2019 in Pharma R&D
In December 2018, the FDA announced it has formally recognized a public database containing genomic information, a huge milestone in the evolving field of precision medicine. Now researchers can use this information to validate their tests instead of having to generate their own data.(more…)